04/02/2023
13:23:58
+44 (0) 203 8794 460
Free Membership
Login
Watchlist
Kurse
Charts
Trades
News
Fundamental
Toplisten
Alerts
Portfolio
Orderbuch
Forum
PLUS1
₿
Krypto
Börse & Märkte
Devisen
Welt Märkte
Follow Feed
Treten Sie unserer Gemeinschaft von Investoren!
JETZT ANMELDEN
Startseite
Investieren
Aktien
USA
NASDAQ
Agenus Inc
(AGEN)
Finanzwerte
Börsenkurse
Charts
Orderbuch
Trades
News
Finanzwerte
Historisch
Financials
Sector Sheet
Search by Sector
FilterX
Agenus Inc. (AGEN) Fundamentals
Agenus Inc is an American biotechnology company. Its main target is immuno-oncology treatments. The company's portfolio consists of therapeutic antibodies and vaccines to treat immuno-oncology illnesses: cancers, shingles, malaria, glioblastoma, and others. Agenus treatments aim, by combining multiple antibody platforms, to stimulate the immune system to recognize and fight cancer cells. The company has been cooperating with companies like Incyte, Merck Sharpe & Dohme, and Recepta Biopharma to achieve over a dozen antibody programs. Some of its products include Prophage, AutoSynVax, QS-21 Stimulon, and others.
SHARE INFORMATION
Market Cap
US$ 807.750.965
Shares Outstanding
304.811.685
Float
289.438.631
Percent Float
94,96%
Short Interest
0,00
Short Percent Float
0,0%
Short Interest Ratio
0,00
Short Interest Date
-
Latest Fiscal Dividend Per Share
US$ 0,00
Latest Fiscal Revenue
US$ 295.664.000
Latest Fiscal EPS
US$ -0,21
Latest Fiscal Date
2021-12-31
DIVIDENDS
Dividend (3 Years)
US$ 0,00
Dividend (5 Years)
US$ 0,00
Ex Dividend Date
-
Dividend Rate
US$ 0,00
Dividend Yield
0,0%
Payment Cash
-
HOLDERS
Institutions
320
Institutional Holdings Date
2023-01-31
Institutional Bought Previous 3 Months
33.126.725
Institutional Holdings Percent
88,6%
Institutional Sold Previous 3 Months
14.614.423
Insider Holdings Date
2022-12-31
Insider Bought Previous 3 Months
34.397
Insider Holdings Percent
2,6
Insider Sold Previous 3 Months
-
Insider Shares Owned
7.975.641
TRADING INFO
52 Week High
US$ 3,37
52 Week Low
US$ 1,25
52 Week High Change
US$ 5,58
21 Day Moving Average
US$ 2,6129
21 Day Extended Moving Average
US$ 2,5926
50 Day Moving Average
US$ 2,5976
50 Day Extended Moving Average
US$ 2,5837
200 Day Moving Average
US$ 2,3723
200 Day Extended Moving Average
US$ 2,6303
10 Day Average Volume
4.860.965
20 Day Average Volume
4.328.967
30 Day Average Volume
4.085.881
50 Day Average Volume
3.971.909
Alpha
0.007894
Beta
1.3089
Standard Deviation
0.225645
R2
0.098165
7 Day Price Change
US$ 0,21
7 Day Percent Change
8,61%
21 Day Price Change
US$ -0,22
21 Day Percent Change
-7,67%
30 Day Price Change
US$ 0,25
30 Day Percent Change
10,42%
Month to Date Price Change
US$ 0,04
Month to Date Percent Change
1,53%
Quarter to Date Price Change
US$ 0,25
Quarter to Date Percent Change
10,42%
180 Day Price Change
US$ 0,08
180 Day Percent Change
3,11%
200 Day Price Change
US$ -0,23
200 Day Percent Change
-7,99%
Year to Date Price Change
US$ 0,25
Year to Date Percent Change
10,42%
Agenus Inc. (AGEN) Key Ratios
PROFITABILITY
EBIT Margin
-181,4%
EBITDA Margin
-173,9%
Pre-Tax Profit Margin
-277,9%
Profit Margin Count
0,57%
Gross Margin
-303,1%
Profit Margin TOT
0,57%
INCOME STATEMENTS
Revenue
US$ 69.638.000
Revenue Per Share
US$ 0,2285
Revenue (3 Years)
US$ -6,16
Revenue (5 Years)
US$ 29,39
FINANCIAL STRENGTH
Price to Tangible Book
-15,40
Total Debt To Equity
23,50
Int Coverage
-2,70
Current Ratio
1,50
Leverage Ratio
-1.060,40
Quick Ratio
1,30
Long Term Debt To Capital
0,95
VALUATION MEASURES
PE Ratio
-3,10
Enterprise Value
US$ 650.405.264
Price to Sales
11,5993
Price to Free Cash
-4,60
PE High Last 5 Years
-3,10
Price To Book
218,60
Price To Cash Flow
50,00
PE Low Last 5 Years
-2,40
Price to Tangible Book
-15,40
MANAGEMENT EFFECTIVENESS
Receivables Turnover
3,90
Invoice Turnover
0,00
Assets Turnover
0,10
Return Assets
-51,80
Return on Equity
-2.090,88
Return on Capital
-210,43
Agenus Inc. (AGEN) Profile
PROFILE INFO
Issue Type
CS
SEC Type
EQS
Auditor
KPMG LLP
CEO
Garo H. Armen
Emplyoees
441
Last Audit
UQ
CIK
0001098972
Industry
Biotechnology
Sector
Healthcare
NAICS
Biological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address
3 Forbes Road
Lexington, MA 02421-7305
Website
https://www.agenusbio.com
Facsimile
+1 781 674-4200
Telephone
+1 781 674-4400
Email
investor@agenusbio.com
Kürzlich von Ihnen besucht
NASDAQ
AGEN
Agenus
Register now
to watch these stocks streaming on the ADVFN Monitor.
Monitor lets you view up to 110 of your favourite stocks at once and is
completely free
to use.
Melden Sie sich bei ADVFN an
Jetzt registrieren
Der Markt LS (Lang&Schwarz) wird als Realtime Indikation kostenlos angezeigt und bietet Ihnen außerbörsliche Realtime Aktienkurse in der Zeit von Mo-Fr 08:00 bis 23:00, Samstags 10:00 bis 13:00 und Sonntags an.
NYSE und AMEX Kurse sind um mindestens 20 Minuten zeitverzögert.
Alle weiteren Kurse sind um mindestens 15 Minuten zeitverzögert, sofern nicht anders angegeben.
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende
Allgemeine Geschäftsbedingungen
Investitionen Warnung
Copyright © 1999 - 2023
Datenschutzrichtlinie
Zustimmungseinstellungen
ADVFN UK
Investors Hub
ADVFN Italy
ADVFN Australia
ADVFN Brazil
ADVFN Canada
ADVFN Germany
ADVFN Japan
ADVFN Mexico
ADVFN France
ADVFN US
P: V:de D:20230204 13:23:58